Appropriate Use Criteria for Molecular Breast Imaging
Journal of Nuclear Medicine Technology, vol. 53, pp. 287–297
Abstract
Molecular breast imaging (MBI) with 99mTc-sestamibi has evolved remarkably since its inception more than 2 decades ago. Compared with prior iterations of the technology, the high-resolution dedicated breast imaging gamma camera systems offer improved sensitivity with the use of dual-head solid-
Authors 10
-
Brown University · Rhode Island Hospital · Lifespan
Affiliation as printed
Alpert Medical School of Brown University and Rhode Island Hospital, Providence, Rhode Island; edibble@lifespan.org
Alpert Medical School of Brown University and Rhode Island Hospital, Providence, Rhode Island
-
Champalimaud Foundation · Leiden University
Affiliation as printed
Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal, and Leiden University Medical Centre, Leiden, The Netherlands
-
The University of Texas MD Anderson Cancer Center
Affiliation as printed
University of Texas MD Anderson Cancer Center, Houston, Texas
-
University of Wisconsin–Madison · University of Wisconsin Carbone Cancer Center
Affiliation as printed
Department of Radiology, University of Wisconsin School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
-
Lioe‐Fee de Geus‐Oei Aachen
Leiden University · Leiden University Medical Center
Affiliation as printed
Leiden University Medical Centre, Leiden, The Netherlands
-
Affiliation as printed
Mayo Clinic, Rochester, Minnesota
-
Affiliation as printed
Radiologic Associates of Middletown, Middletown, Connecticut
-
The University of Texas MD Anderson Cancer Center
Affiliation as printed
University of Texas MD Anderson Cancer Center, Houston, Texas
-
University of California, Los Angeles
Affiliation as printed
UCLA, Los Angeles, California; and
UCLA, Los Angeles, California
-
Affiliation as printed
Huntsman Cancer Institute, Salt Lake City, Utah
Cited by 4 stored of 5
4 results
No patents citing this paper on Lens.org (checked 2026-10-11).